March Symposium: New Technologies for Parkinson's Disease Q&A (2021)

In this webinar, Dr. Martin McKeown, a movement disorder specialist, delved into multiple research areas, outlining the decision-making process for research projects, and exploring topics like neuromodulation, patient monitoring, neurobiofeedback, and myelin imaging. Responding to inquiries from participants, Dr. McKeown provided insights into diverse subjects such as the utilization of a leukemia drug in Parkinson's disease, the projected timeline for the availability of vestibular stimulation, gut microbiome research and its potential manipulation through probiotics and antibiotics, and strategies to prevent research duplication. The webinar also touched on the possible future advancements in the delivery of levodopa, specifically discussing the prospects of transdermal patches.

**Disclaimer: These sessions are designed to provide general education and are not intended for individual advice and/or clinical care. The information conveyed in this recording was accurate at the time of presentation.**